JEREE PAUL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MAITLAND, FL NPI 1780348441
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FL Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$388.89
- Category: General Payments
- Program years: PY2022–2023
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $125.85 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $125.85 | 6 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.03 | 2 |
| Lilly USA, LLC | $30.71 | 1 |
| Acerta Pharma LLC | $20.59 | 1 |
| Amgen Inc. | $16.08 | 1 |
| Novo Nordisk AS | $13.44 | 1 |
By program year
Records — PY2023 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1002493693 | Novo Nordisk Inc | $13.44 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1012054587 | AstraZeneca Pharmaceuticals LP | $20.59 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1020352983 | Amgen Inc. | $16.08 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1033123997 | Lilly USA, LLC | $30.71 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996742681 | Boehringer Ingelheim Pharmaceuticals, Inc. | $21.83 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 997106529 | Boehringer Ingelheim Pharmaceuticals, Inc. | $23.20 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.